The weekly litigation news digest is live. Subscribe now

IP Verse

Combinations And Modes Of Administration Of Therapeutic Agents And Combination Therapy - EP3248600

The patent EP3248600 was granted to Abraxis Bioscience on Jun 24, 2020. The application was originally filed on Feb 21, 2006 under application number EP17165979A. The patent is currently recorded with a legal status of "Revoked".

EP3248600

ABRAXIS BIOSCIENCE
Application Number
EP17165979A
Filing Date
Feb 21, 2006
Status
Revoked
Jun 25, 2021
Publication Date
Jun 24, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKApr 24, 2020ELKINGTON AND FIFEADMISSIBLE
TEVA PHARMACEUTICALSApr 9, 2020D YOUNGADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004143004
DESCRIPTIONUS2005004002
DESCRIPTIONUS2006003931
DESCRIPTIONUS2006013819
DESCRIPTIONUS5470571
DESCRIPTIONUS5558864
DESCRIPTIONUS5690928
DESCRIPTIONUS5859018
DESCRIPTIONUS5916596
DESCRIPTIONUS6096331
DESCRIPTIONUS6506405
DESCRIPTIONUS6537579
DESCRIPTIONUS6566405
DESCRIPTIONWO0064437
DESCRIPTIONWO2005000900
DESCRIPTIONWO2005117978
DESCRIPTIONWO2005117986
OPPOSITIONEP0577215
OPPOSITIONEP0797988
OPPOSITIONEP1632259
OPPOSITIONWO0071079
OPPOSITIONWO0189522
OPPOSITIONWO2005030171
OPPOSITIONWO9503036
SEARCHWO0189522

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents